ω-Imidazolyl-alkyl derivatives as new preclinical drug candidates for treating non-alcoholic steatohepatitis

dc.contributor.author	Diesinger, T.
dc.contributor.author	Lautwein, A.
dc.contributor.author	Buko, V.
dc.contributor.author	Belonovskaya, E.
dc.contributor.author	Lukivskaya, O.
dc.contributor.author	Naruta, E.
dc.contributor.author	Kirko, S.
dc.contributor.author	Andreev, V.
dc.contributor.author	Dvorsky, R.
dc.contributor.author	Buckert, D.
dc.contributor.author	Bergler, S.
dc.contributor.author	Renz, C.
dc.contributor.author	Muller-Enoch, D.
dc.contributor.author	Wirth, T.
dc.contributor.author	Haehner, T.
dc.date.accessioned	2021-04-22T07:49:33Z
dc.date.available	2021-04-22T07:49:33Z
dc.date.issued	2021-09
dc.identifier.citation	ω-Imidazolyl-alkyl derivatives as new preclinical drug candidates for treating non-alcoholic steatohepatitis / T. Diesinger, A. Lautwein, V. Buko, E. Belonovskaya, O. Lukivskaya, E. Naruta, S. Kirko, V. Andreev, R. Dvorsky, D. Buckert, S. Bergler, C. Renz, D. Muller-Enoch, T. Wirth, T. Haehner // Physiological Reports. – 2021. – № 9. – Р. 1-20.	ru_RU
dc.identifier.uri	http://elib.grsmu.by/handle/files/24307
dc.language.iso	en	ru_RU
dc.title	ω-Imidazolyl-alkyl derivatives as new preclinical drug candidates for treating non-alcoholic steatohepatitis	ru_RU
dc.type	Article	ru_RU